共 50 条
Vitamin D supplementation may improve back pain disability in vitamin D deficient and overweight or obese adults
被引:11
|作者:
Brady, Sharmayne R. E.
[1
]
Naderpoor, Negar
[2
]
de Courten, Maximilian P. J.
[1
,3
]
Scragg, Robert
[4
]
Cicuttini, Flavia
[1
]
Mousa, Aya
[2
]
de Courten, Barbora
[2
]
机构:
[1] Monash Univ, Sch Publ Hlth & Prevent Med, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia
[2] Monash Univ, Sch Publ Hlth & Prevent Med, Monash Ctr Hlth Res & Implementat, 43-51 Kanooka Grove, Clayton, Vic 3168, Australia
[3] Victoria Univ, Ctr Chron Dis Prevent, Melbourne, Vic 3021, Australia
[4] Univ Auckland, Sch Populat Hlth, Auckland, New Zealand
来源:
基金:
英国医学研究理事会;
关键词:
Vitamin D;
Back pain;
Overweight and obesity;
Randomised controlled trial;
NONSPECIFIC MUSCULOSKELETAL PAIN;
DWELLING OLDER-ADULTS;
BONE-MINERAL DENSITY;
25-HYDROXYVITAMIN D;
MODIC CHANGES;
ASSOCIATION;
QUESTIONNAIRE;
RELIABILITY;
PREVALENCE;
PROTOCOL;
D O I:
10.1016/j.jsbmb.2018.09.005
中图分类号:
Q5 [生物化学];
Q7 [分子生物学];
学科分类号:
071010 ;
081704 ;
摘要:
Back pain is currently the greatest cause of disability worldwide, and there are very limited therapeutic options available. Vitamin D deficiency and obesity are both risk factors for back pain. The few randomised controlled trials examining the effects of vitamin D supplementation on back pain have methodological limitations and largely include non-vitamin D deficient participants. Thus, the aim of this study was to determine whether vitamin D supplementation improves back pain symptoms in vitamin D deficient and overweight or obese, otherwise healthy adults. Sixty-five overweight or obese adults (BMI >= 25 kg/m(2)) with vitamin D deficiency (25-hydroxyvitamin D [25(OH)D] concentrations <= 50 nmol/L) were randomised to a bolus oral dose of 100,000 IU followed by 4000 IU cholecalciferol/day or matching placebo for 16 weeks. We measured 25(OH)D concentrations (chemiluminescent immunoassays) and self-reported back pain (Chronic Pain Grade Questionnaire) before and after the intervention. Lifestyle habits including sun exposure, physical activity, and diet were collected using questionnaires. Fifty-four participants completed the study, of which 49 had complete data for back pain and were included in the present analyses (31 M/18 F; mean +/- SD age: 31.8 +/- 8.9 years; BMI: 31.1 +/- 4.5 kg/m(2)). After the 16-week intervention, 25(OH)D levels increased significantly with vitamin D supplementation compared with placebo (55.7 +/- 20.9 versus 3.9 +/- 14.4 nmol/L, respectively, p < 0.001). There were no significant differences between vitamin D and placebo groups in change in back pain intensity or disability scores (all p > 0.05). However, in those with 25(OH)D concentrations < 30 nmol/L at baseline (n = 20), there was a significantly greater reduction in back pain disability scores in the vitamin D group compared with placebo, after adjusting for important covariates known to affect vitamin D status and/or back pain (b [95%CI] = -11.6 [-22.4,-0.8], p = 0.04). Our findings suggest that vitamin D supplementation in overweight or obese and markedly vitamin D deficient adults (25(OH)D < 30 nmol/L) may improve back pain disability. Although treating severe vitamin D deficiency is recommended for optimising bone health, this study suggests it may also improve back pain. Hence, testing for vitamin D deficiency in those with back pain who are overweight or obese may be warranted.
引用
收藏
页码:212 / 217
页数:6
相关论文